Philip Morris
Get - the - Lead - Out Guru Challenged A Decade-Old Scientific Argument Over the Effects of Low-Level Lead on Iq Turns Nasty Following Allegations of Misconduct
Fields
- Author
- Palca, J.
- Area
- LOGUE,MAYADA/OFFICE
- Type
- MAGA, MAGAZINE ARTICLE
- PHOT, PHOTOGRAPH
- Site
- N426
- Request
- Stmn/R1-072
- Named Organization
- Atlantic Richfield
- Case Western Reserve Univ
- Centers for Disease Control
- Environmental Criteria Assessment Office
- Epa, Environmental Protection Agency
- Harvard Univ
- Hogan Hartson
- Hunton Williams
- Inst for Child Health
- Intl Lead Zinc Research Org
- Justice Dept
- Lead Poisoning Prevention Branch
- Milbank Memorial Fund
- New England Journal of Medicine
- NIH, Natl Inst of Health
- Office of Scientific Integrity
- Pediatrics
- Science
- Sharon Steel
- Univ of London
- Univ of NC Chapel Hill
- Univ of Pittsburgh
- Univ of Va
- Uv Industries
- Advisory Panel
- Case Western Reserve Univ
- Named Person
- Bellinger, D.
- Binder, S.
- Bushes
- Duffield, J.
- Ernhart, C.B.
- Fisherow, W.B.
- Geneson, D.F.
- Grant, L.
- Graves
- Jenkins, B.S.
- Kupper, L.
- Mishkin, B.
- Needleman, H.L.
- Quayle, D.
- Reid, H.
- Scarr, S.W.
- Smith, M.
- Weiner, S.L.
- Hirayama
- Binder, S.
- Document File
- 2025545619/2025546382/Harvard University Office of
- Continuing Education Short Course Program Harvard School
- of Public Health
- Continuing Education Short Course Program Harvard School
- Litigation
- Stmn/Produced
- Author (Organization)
- Science
- Master ID
- 2025545673/6381
Related Documents:- 2025545673-6381 Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025545684 Telephone Locations and Protocol
- 2025545689-5696 Risk Assessment for Carcinogens: A Comparison of Approaches of the Acgih and the Epa
- 2025545697 Hps Newsletter Interview with A Risk Expert
- 2025545698-5711 Science and Its Limits: the Regulator's Dilemma
- 2025545713-5721 Risk / Benefit Analysis
- 2025545722-5725 Risk Management Commentary for Dr. D. Allan Bromley Assistant to the President for Science and Technology
- 2025545726-5729 Risk Assessment and Comparisons: An Introduction
- 2025545750-5792 Risk Assessment of Chemical Carcinogens: Is It Time for A Change?
- 2025545795-5799 Tools of Risk Analysis Applications of Epidemiology
- 2025545800-5810 Notice of Intended Changes - Benzene
- 2025545811-5822 Epidemiology in Risk Assessment for Regulatory Policy
- 2025545824-5850 Risk Analysis in Environmental and Occupational Health Use of Animal and Other Data As Predictors of Human Risk
- 2025545851-5871 Risk Analysis in Environmental and Occupational Health Uncertainties in Predicting Human Risks
- 2025545872-5881 How Do Cancer Risks Predicted From Animal Bioassays Compare with the Epidemiologic Evidence? the Case of Ethylene Dibromide
- 2025545882-5887 Use of Biological Assays in Short-Term Assessment of Inhaled Substances
- 2025545888
- 2025545889-5891 Risk Analysis in Environmental and Occupational Health Are Your Mushrooms Safe to Eat?
- 2025545892-5899 the Rat As An Experimental Animal
- 2025545901-5907 Non-Cancer Endpoints
- 2025545910-5939 Cancer Facts & Figures - 890000
- 2025545940-5941 Cancer Facts & Figures - 890000
- 2025545945-5948
- 2025545949-5958 the Question of Thresholds for Radiation and Chemical Carcinogenesis
- 2025545959-5980 Are There Thresholds for Carcinogenesis? the Thorny Problem of Low-Level Exposure
- 2025545981-5990 Perspectives on Comparing Risks of Environmental Carcinogens
- 2025545991-5998 Acceptable Cancer Risks: Probabilities and Beyond
- 2025546000-6011 Ideas in Pathology Pivotal Role of Increased Cell Proliferation in Human Carcinogenesis
- 2025546012-6017 Cell Proliferation in Carcinogenesis
- 2025546019-6027 the Role of Expert Judgement in Risk Analysis
- 2025546029-6039 the Respiratory Tract As A Route of Exposure
- 2025546040-6045 the Respiratory Tract As A Portal of Entry for Toxic Particles
- 2025546047-6062 Limitations to the Use of Employee Exposure Data on Air Contaminants in Epidemiologic Studies
- 2025546063-6083 Benefit - Cost Analysis of Environmental Regulation: Case Studies of Hazardous Air Pollutants
- 2025546086-6089 Legislative and Regulatory Aspects of Risk
- 2025546090-6099 Connecticut's Dioxin Ambient Air Quality Standard
- 2025546100-6103
- 2025546105 Annals of Radiation Calamity on Meadow Street
- 2025546106 Caution Urged When Using Insect Repellents
- 2025546116 Volatile Organics and Inorganics Action Levels 900400
- 2025546134-6135 Summary of Radon Test Results of the Household Testing Program
- 2025546141-6145 Introduction to Discussion Sessions
- 2025546146-6149 Risk Assessment in Environmental and Occupational Health Risk of Alar (Daminozide)
- 2025546150-6160 Intolerable Risk: Pesticides in Our Children's Food
- 2025546161-6162 Pesticides, Risk, and Applesauce
- 2025546163-6168 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546169 Daminozide / Udmh
- 2025546170-6172 the Relative Risk of Daminozide (Alar / Kylar) Use
- 2025546173 Be Most Wary of Nature's Own Pesticides
- 2025546174-6175 A Movie Star Pares the Apple Industry
- 2025546176-6183 Summary of Toxicology Data on Daminozide and Udmh
- 2025546184-6194 Attachment I Graphs of Data From NCI / Ntp 83 Daminozide
- 2025546195-6196
- 2025546197-6202 Daminozide Special Review Technical Support Document - Preliminary Determination to Cancel the Food Uses of Daminozide
- 2025546203-6224 Regulatory Decision - Making Under Uncertainty: the Case of Alar
- 2025546226 Epa Moves to Reassess the Risk of Dioxin Urged on by the Scientific Community, Epa Is Developing A New Model for Estimating Dioxin's Risk
- 2025546227 US Government Orders New Look at Dioxin the Environmental Protection Agency Is Evaluating Data From the Past Decade That Suggest Dioxin's Toxicity May Be Overestimated. A Risk Assessment Model Based on Biological Mechanism Is Being Drawn Up.
- 2025546228-6235 Dioxin Toxicity: New Studies Prompt Debate, Regulatory Action New Data on Dioxin's Effect on Humans, A Clearer Picture of the Cellular Events It Precipitates, and New Animal Toxicity Studies May Provide Epa with A Firm Basis for Regulation
- 2025546236-6250 the Regulation of Gene Expression by 2,3,7, 8-Tetrachlorodibenzo-P-Dioxin
- 2025546251-6253 Dioxin Risks Revisited Armed with A New Understanding of How Dioxin Works on the Molecular Level, A Number of Scientists Are Challenging Epa to Change the Way It Does Risk Assessment
- 2025546255-6258 Lead Toxicity Case Study for Short Course on Risk Analysis in Occupational and Environmental Health 910904 - 910906
- 2025546259-6267 Lead
- 2025546268-6275 Lead in Bone: Implications for Toxicology During Pregnancy and Lactation
- 2025546276-6281 the Long-Term Effects of Exposure to Low Doses of Lead in Childhood An 11 - Year Follow-Up Report
- 2025546282-6285
- 2025546298-6321 Review 890000 Alice Hamilton Lecture Lead and Human Health:Background and Recent Findings
- 2025546323-6348 Traps and Errors in Risk Analysis
- 2025546349-6356 Health Risks the Perception of Reality and the Realty of Perception
- 2025546357-6362 Communicating Risk Under Title III of Sara: Strategies for Explaining Very Small Risks in A Community Context
- 2025546363-6368 Industrial Risk Perceptions
- 2025546369-6370 Too Many Rodent Carcinogens: Mitogenesis Increases Mutagenesis
- 2025546371-6373 Has Risk Assessment Become Too 'conservative'?
- 2025546374-6378 Health and Safety Risk Analyses: Information for Better Decisions
- 2025546379-6381 Telling Reporters About Risk Dealing with Reporters Needn't Be the Least Agreeable Part of the Job.
- Characteristic
- EXTR, EXTRA
- MARG, MARGINALIA
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- okp02a00
Document Images
SrIENCE, Vol. 253, No. 5022, pages 842 - 844 (23 August 1991).
Get-the-Lead-Out Guru Challenged
A decade-old scienti f ic argument over the ef fects of low-level lead on IQ turns nasty following
allegations of misconduct
AS AN ENVIROhMEhTAL BOGEYhU2:, LEAD'S
hard to beat. It ranks right up there with
asbestos, dioxin, and nuclear waste. Vice
President Dan Quayle has even suggested
that lead in the drinking water at the vice
presidential mans:,on might have caused the
Bushes' bouts widi Graves' disease.
But, irrational f:ars aside, there's no ques-
tion that high lead levels can cause brain
damage-it's only at low levels of exposure
that there is still a debate about what amount
of lead in the blood can cause detectable
behavioral and medical problems. And that
debate has been tainted by a festering, 10-
year-old dispute over the credibility of data
published by Herbert Needleman of the
University of Pittsburg, a world-renowmed
researcher on lead toxicity and leading ad-
viser to the gove;mment on lead issues. Now,
in the wake of a government lawsuit against
the owners of a lead smelter in which
Needleman was to have testified-but never
did because the case was settled out of
court-his critics h.ave filed a complaint with
federal investigators alleging that Need-
leman engaged irn scientific misconduct a
decade ago. They accuse the government of
helping cover up the flaws in his research in
order to deflect criticism of its policy deci-
sions.
To Needleman, the charges are nothing
more than old mud slung with new vigor-
thoroughly debunked criticisms kept alive
by a lead industry desperate to discredit his
research.
Regardless ofwho is right, the Needleman
saga shows how hard it is to put to rest
charges from persistent critics, or, con-
versely, to prove misconduct against an ac-
knowledged leader in a scientific field. But it
also raises additional questions, widely ap-
plicable to other scientific disputes, about
who should have access to data collected
with federal support. And, of course, it
refocuses attention on a matter that is espe-
cially meaningful to a lot of parents: Just
how strong is the link between low-level
lead exposure and :;ntelligence deficits?
The story be:gins with a paper by
Needleman and his colleagues in the 29
March 1979 issue ofThe New England Jour-
nal ofMedicine shoAing that schoolchildren
with what all would agree were "high," but
not actually toxic, lead levels did significantly
poorer in the classroom and had measurably
lower IQs than those with "low" lead levels.
In order to get a clearer picture of exposure,
the researchers had looked at lead concentra-
tions in the children's baby teeth, as well as
the more labile measure of lead in the blood.
Suzanne Binder, chief of the Lead Poisoning
Prevention Branch at the Centers for Disease
Control (CDC) in Atlanta, says that most
people's first reaction to Needleman's study
was "so what?" since the drop in IQ was
only 3 or 4 points. But Binder says policy-
makers came to realize that even a small
drop would be important if it was affecting
millions of children.
Two years after the Journal article ap-
peared, Claire Ernhart, a psychologist now at
crude measure like IQ, except at some of the
highest levels of exposure, just below what
would be considered toxic.
The appearance of the Pediatrics article
touched off wh'at has been a decade-long
personal feud between Ernhan and Needle-
man. They have squared off at numerous
scientific meetings with a vigor that has left
observers shaking their heads. "Personal hos-
tilit} is putting it mildly," says Binder.
But the Needleman/Ernhart squabble
might have remained nothing more than a
classic confrontation between scientists -,vith
starkly opposing views had it not entered, in
1983, into a new and grander forum. The
year before, the Environmental Protection
Agency (EPA) had begun a major review of
national air-qualitv standards for lead and
r wanted to review all
m
a recent data on the
a health effects of lead
o exposures. In an ef-
~0 fort "to resolve major
d
E points of controversy
D
concerning some of
the most important
and controversial"
studies, Lester Grant,
director of the EPA's
environmental criteria
and assessment office,
convened a special
panel to look into
both Needleman's
and Ernhart's work
(Science, 25 Novem-
ber 1983, p. 906).
The panel traveled
Clearing the Ar. Herbert Needleman says the lead industry is
behind attempts to discredit his research.
Case Western Reserve University, and her
colleagues fired the first shot across
Needleman's bow. Writing in the journal
Pediatrics, they suggested that there were
serious methodological flaws in the Need-
leman paper. Ernhart argued that Needleman
had not done an adequate job of controlling
for confounding variables-other factors such
as poor schools orparental neglect that might
explain the difference in IQ scores-and had
performed so many comparisons that he was
bound to come up with a few that were
statistically significant merely by chance.
Ernhart's own %.rork suggested that most lead
effects were too small to be detected by a
to Needleman's lab, examined some of his
data, and decided there were several prob-
lems with the study. Specifically, the panel
members concluded that Needleman had
used inappropriate measures to categorize ~~'
lead exposure and had not provided suff~-s~' ~
~
cient justification for excluding subjects,
from the study. Moreover, they expressed
concern about missing data, and some of
the statistical analyses Needleman had em-
ployed, all of which led them to conclude
that the study results "neither support nor
refute the hypothesis that low or moderate
levels of [lead] exposure lead to cognitive or
behavioral impairments in children." The
842 SCIENCE, VOL. 253

}
panel reached the same conclusion about
two of Ernhart's papers, which they also
criticized for methodological flaws.
While Errthart took the panel's rebuke
quietly, IvTeedleman fought back. He in-
sisted that the panel's conclusions were
flawed, and he wrote a spirited, point-by-
point refutation of the criticisms levied at his
work. He blasted Grant for printing the
report before sending it to him for review,
accusing him of violating an agreement he
said he and Grant had made. Needleman
"It was-,really the
data a,n alysis strategy
that I t'ceoked at, and
that to'rte [was]
outrezgle,aus.
-Sandra W. Scarr
also performed some new analyses of his
original data, and by the time the panel's
report was presented to the EPA advisory
panel that would decide on the new lead
standards, both Grant and the advisory panel
had made a IEIO-degree turn. Now they
were convinced that Needleman's original
conclusions were accurate. Indeed, those
conclusions subsequently became part of
the scientific basis for the revised air lead
standards EPA, promulgated in 1986.
But Ernhart was not daunted by this set-
back; she continued to criticize Needleman's
work. And her willingness to argue that the
link between l,mw-level lead exposure and
behavioral problems was being overstated
won favor with the lead industry. As early as
1982, she had agreed to testify in favor of the
industry's positio n before an EPA panel con-
templating phasing out all leaded gasoline-
Just last year she wrote to Senator Harry Reid
(D-NV) telling him that basing legislative
action on Needleman's findings would be an
"egregious error.... Serious problems in the
Needleman work have long been noted by
scientists working in this field." And she
appeared from time to time as an expert
witness in cases involving lead contamination
and cleanup, w.hich brought her feud with
Needleman into a new arena: the courtroom.
Their latest fieeoff-which has escalated
beyond the hazards of lead to the high-
stakes "game" of scientific fraud and mis-
conduct charges--began in 1990 with a
Superfund case brought by the government
against Sharon Si:eel, UV Industries, and
Atlantic Richfield Company. Over a period
of several decades, each company had had a
financial interest irt a defunct lead smelter in
23 AUGUST 1991
Midvale, Utah. The government case sought
money for the cleanup of some 250 acres of
tailings from a milling facility that prepared
the lead ore for the smelter. The govern-
ment intended to show that the tailings
posed a health risk to children living in the
area and hired none other than Herbert
Needleman as an expert witness to testify to
the dangers the tailings posed.
For their part, the corporations' lawyers
turned to Ernhart as an expert witness. In
addition, the defense team brought in
University of
Virginia psy-
chologist San-
dra Wood Scarr,
whose work fo-
cuses on factors
affecting child-
ren's educational
development.
She had also
served as a mem-
ber of the EPA
panel that had
examined Needleman and Ernhart's re-
search back in 1983. Although Scarr had
been among the most critical of Needle-
man's work then, she says she paid no fur-
ther attention to
it after the panel
had wrapped up
its business.
Now, she and
Ernhart felt that
they could dam-
age the govern-
ment's case by
demonstrating
what they had
long believed:
that Needleman's
1979 paper-which they say has been
"highly influential in the establishment of
regulatory policies"-was seriously flawed.
They asked to see Needleman's raw data
for the 1979 study. He agreed to release
some of the unpublished material, but not
the tapes containing his raw data. Needl-
eman argued, in an affidavit dated 27 July
1990 that, in part because he was in the
throes of moving his lab, "it would be a
substantial hardship for me to find the
proper data tape for this 11-year-old study."
He added that since the study had been peer
reviewed and the data examined by the
EPA, there had already been adequate op-
portunity to establish'the legitimacy of his
results.
Needleman did say in his affidavit, how-
ever, that he would be willing to let "any
scientist who wishes to examine the complete
printouts of the raw data from the study
come to my laboratory in Pittsburgh for as
long as he or she wants." So on 20 September
last year, Scarr and Ernhart, along with de-
fense lawyers in the lead smelter case, traveled
to Pittsburgh to take Needleman up on his
offer. When they arrived, they were directed
by Justice Department attorney W. Be
jamin Fisherow, who was acting for th
government, to a bare room where they
were given six volumes of computer print-
outs containing Needleman's initial analyses
of his data. Scarr and Emhart began plow-
ing through the analyses, although they
were hampered by the fact that the data
were coded, and they were given an incom-
plete key. Needleman himself would not
talk to them.
For his part, Needleman steadfastly insists
that he will happily share his data with
anyone who has a legitimate interest and
will answer any questions he is asked. But,
he says, "I'm just not going to make it easy
for people who are going to harass me," a
category to which he assigns Scarr and
Ernhart.
Since Scarr and Ernhart weren't able to
get through all the computer printouts in
one day, they returned to the lab the next
morning. But this time, Fisherow asked
them to sign a document saying they would
6`Serious problems in
the 1Veedleman work
have long been noted
by scientists working
in this f aeld."
-Claire B. Ernh;u-t
treat all the data they were being shown in
absolute confidence and would discuss it
only in oral testimony before the court.
While such agreements are not uncommon
for litigation involving private corporations,
Scarr and Ernhart were appalled at what
they saw as an attempt to gag them, and
they refused to sign. After a few hours,
lawyers for both sides decided that the visit
would have to end, so Scarr and Ernhart
gathered their notes and left.
Scarr says that even with only one day to
study the analyses, she felt she had a clear idea
ofwhat had happened back in 1979. "It was
really the data analysis strategy that I looked
at, and that to me [was] outrageous." Ac-
cording to Scarr, the printouts show that
Needleman's first set of analyses failed to
show a relationship between lead level anc'
subsequent intelligence tests. "Not one sin
variable came out as statistically different be-
tween the top 10% [oflead-exposed children]
NEWS & COMVAENT 843

and the bottom 10%ofthe sample," she says.
It was only by rerunning the analyses, elimi-
nating important variables that might also
causes changes in IQ, scores, that "he got
results he wantr:d."
Scarr's harsh view of Needleman might
never have become public, however, had it
not been for a curious legal twist--one with
potentially major ramifications for the avail-
ability of government research data. Before
Scarr and Ernhart had a chance to present
their conclusions about Needleman and his
data in the Utah court case, the litigants
settled the case. The defendants agreed to
pay the government $63 million-the cost of
cleaning up the lead tailings. Losing the
chance to put the charges on record in open
court, Scarr and Emhart wrote a report that
they planned to send i:o the National Insti-
tutes of Health (NIH) Office of Scientific
Integrity (OSI), since Needleman's study had
been funded with NIH money. But 4 days
before the settlement agreement was an-
nounced, the government lawyers took a
remarkable step: They asked the court to
force Scarr and Ernhart to return their notes
on the Needleman data and refrain from
speaking about what they had found-essen-
tially the same rules S<:arr and Emhart refused
to agree to back in Pittsburgh when they
were poring over Ne :dleman's printouts.
Scarr and Ernhart immediately con-
.ded-and believe today-that the gov-
,inment was trying to protect Needleman
because his research forms the backbone of
government lead policy.
Government lawyer Fisherow will not say
explicitly why the government sought to
gag Scarr and Ernhart, but Needleman's
affidavit gives a rationale: "Releasing these
raw data to the defendants here will mean
that the industry will have the capacity, if it
so chooses, to manipula.te this data as it sees
fit. While any credible researcher should be
willing to have the accuracy ofhis published
results debated, the standards of conduct in
the scientific communi.ry do not extend to
making raw data available to advocates of
opposing views who then are presented with
the opportunity to misuse them."
Scarr and Emhart weren't buying that ar-
gument. They hired David F. Geneson of the
Washington, D.C., legal firm Hunton &
Williams to fight the,g.ag order. Geneson
contended to the court that the govern-
ment's request was an abridgement of Scarr
and Ernhart's First Amendment rights, and
that there was no good cz use to suppress data
that had been gathered with public money.
This argument certainly rings true with
.vyers who specialize in misconduct issues.
It's hard to imagine a legitimate basis for
the federal government asking for data to be
buried," says one such_ attorney, Barbara
Mishkin of the Washington, D.C., firm of
Hogan and Hartson.
Needleman, however, has been trying to
make just such an argument by saying that
the lead industry has tried to twist his data
to make it appear to prove things it doesn't
actually prove. Mishkin isn't impressed.
"The cigarette industry is always putting
out its own dubious analysis of data. No-
body pays any attention to it."
On 26 April this year, federal district
court judge Bruce S. Jenkins agreed with
Mishkin's point, writing that "there is some-
thing inherently distasteful and unseemly in
secreting either the fruits or seeds of scien-
tific endeavors." And that freed Scarr and
Ernhart to tell their doubts about Needle-
"l,just do not want to.,.
spend the rest of my life
responding to t7ZgJlU.
My reputation is
secure."
-Herbert L. Needleman
man and his data to anyone they chose.
Their first step was to write a report based
on their day-and-a-halfvisit to Needleman's
lab, and they have sent a copy to the OSI.
OSI officials are considering whether
Needleman's actions fall under their juris-
diction, or whether Scarr and Ernhart's
analyses fall under the rubric of legitimate
scientific difference of opinion. Jane
Duffield, a spokeswoman for the University
of Pittsburgh, where Needleman did his
work, says OSI has not contacted the uni-
versity concerning any investigation and
adds that "we're not investigating Dr.
Needleman and we stand behind his work."
From Needleman's point of view, this
latest round of charges is nothing more than
harassment from the lead industry. "I just
do not want to...spend the rest of my life
responding to trivia," he says. "My reputa-
tion is secure at least among people whom I
count as important. I'm a forward looking
person, and I have much more important
questions to answer." And indeed, Needle-
man has supporters inside and outside the
EPA who have seen his data and find noth-
ing to be suspicious of. Frequent co-author
David Bellinger, a psychologist and epide-
miologist at Harvard University, says there
is no substance to Scarr's charge that
Needleman eliminated variables from his
analyses until he got the results he wanted.
"I've worked with the data set, and nothing
has ever come to light to make me concerned
about that issue." Adds former EPA panel
member Larn, Kupper, a biostatistician at
the University of North Carolina, Chapel
Hill, "I never thought there was any mis-
conduct."
Meanwhile, Ernhart vociferously defends
herself against Needleman's charges that
she is merely serving the lead industn, in its
attack on him. Yes, she accepts research
support from the International Lead Zinc
Research Organization, she admits, but says
that hasn't affected her objectivity. Her
objections to Needleman's conclusions be-
gan, she argues, long before she received
any lead industry money. Scarr, too, bristles
at the suggestion that her objectivity is
tainted. "I have no ties to the lead indus-
try," she says. "I don't care what happens to
them." What bothers Scarr is that policy
decisions are being made based on what she
is convinced is flawed work that no one
wants to take the time to examine closely. ,
"There's just something wrong about the
procedure here, and the role that science is
playing in this."
Not so, says EPA's Grant. "The particular
studies that are at issue there, and the pub-
lications that they are fighting about, are
more or less passe," he maintains. "We now
have a decade of additional research that
confirms lead effects on IQ and behavioral
development at much lower levels than the
ones they were talking about."
But even this point of view is contested by
some. Sanford L. Weiner, a political scien-
tist based in Boston who works for the
Milbank Memorial Fund, says he, like
Ernhart and Scarr, believes policy actions
have outpaced the science. Weiner says it is
hard to find a study that clearly demon-
strates adverse health effects from lead levels
belo-w 25 micrograms per deciliter of blood,
the point that the CDC currently uses as its
cutoff for lead poisoning. Indeed, agrees
Marjorie Smith, a psychologist at the Insti-
tute for Child Health at the University of
London who directed a lead study in En-
gland, 10 micrograms per deciliter-the
level to which EPA wants to reduce the lead
standard-is "unrealistically low" and would
"cause unnecessary anxieties for parents."
Binder says that it is extremely hard to
find people who don't have strong opinions
about lead in the environment. "Either
they're working on this because they con-
sider it to be an incredible problem, and it's
worth devoting their life to, or they think
everybody else is an idiot, and they have to
prove that evenone else is wrong."
So will the day come when both sides can
reach a consensus: Not likely, says Binder:
"They will all go to their graves thinking the
other side is made up of total idiots."
JOSEPH PALCA
844 SCIENCE, VOL. 253
